Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2011 FY- Text added to 2012 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
aldoxorubicin, Annex, behavior, cardiac, compassionate, condensed, dacomitinib, ductal, earliest, fluoropyrimidine, fourth, gemcitabine, ibrutinib, Iclusig, Infinity, Instruction, likelihood, lymph, nadir, neutropenia, NOL, opposed, par, postulated, proven, simply, speculative, spleen, Synribo, TKI, Votrient
Removed:
accumulating, accumulation, age, Amnolake, applied, Ariad, arose, ASU, auditing, Avenue, Beckman, BioMarin, brand, breathing, Bulletin, complication, consecutive, consolidate, dasatinib, defining, die, Diego, differentiate, discontinued, dollar, dyspnea, ending, enrolled, escalating, exempt, existed, expression, fatal, fatigue, fever, forecasting, funded, Geyer, guarantee, Hagop, hematologic, increasing, incremental, incurring, Israel, Kantarjian, leukemic, library, Louisiana, Madison, Merck, mg, microbiology, misleading, morphologic, naturally, nilotinib, older, Onyx, optimal, pazopanib, pericardial, poor, prolongation, properly, prospectively, pulmonary, QTc, RAS, recommend, recurrence, regain, rent, represented, resumed, rhythm, scheduled, security, selectively, SmithKline, Southwestern, sublease, swelling, syndrome, TRF, unacceptable, undergo, veterinary, Virtually, Xencor
Valuein 2011 FY filing- Value in 2012 FY filing
Original filings
Filing view